News & Updates
Filter by Specialty:

Is hypotension avoidance better than hypertension avoidance in noncardiac surgery?
The incidence of major vascular complications among patients who underwent noncardiac surgery is similar between hypotension- and hypertension-avoidance strategies, reports a study.
Is hypotension avoidance better than hypertension avoidance in noncardiac surgery?
04 May 2023
Lower phase angle linked to CKD progression in T2DM
A Singapore study has found a previously overlooked connection between bioelectrical impedance analysis (BIA)-derived lower phase angle and chronic kidney disease (CKD) progression, mediated by matrix metalloproteinase-2 (MMP-2), in patients with type 2 diabetes mellitus (T2DM).
Lower phase angle linked to CKD progression in T2DM
04 May 2023
Cash transfers ease functional impairment in elderly
A study in India has shown the effectiveness of a small cash transfer in alleviating short-term functional impairment among older people who are living alone. However, cash transfers do not produce a clinically or statistically significant decrease in depression and show no impact on food security.
Cash transfers ease functional impairment in elderly
04 May 2023
Molnupiravir cuts hospitalization, death in COVID-19 patients at high risk of progression
An emulation of a randomized target trial suggests that molnupiravir may reduce hospital admission or death in adults who have tested positive for COVID-19 during the predominance of Omicron who were at high risk of progression to severe disease.
Molnupiravir cuts hospitalization, death in COVID-19 patients at high risk of progression
04 May 2023
Poor awareness of hypertension self-management practices persists: study
A recent study conducted in Nigeria from December 2019 to February 2020 has revealed many individuals with little to no awareness of hypertension self-management practices.
Poor awareness of hypertension self-management practices persists: study
03 May 2023
NOACs proven safe, effective in Asians with AF
Use of nonvitamin K antagonist oral anticoagulants (NOACs) helps prevent thromboembolic events in Asian patients with atrial fibrillation (AF), with fewer bleeding events relative to warfarin therapy, according to the results of a study presented at the recent EHRA 2023.